Who Supplies Indomethacin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Indomethacin exports, with 139+ registered manufacturers shipping to buyers across 70+ countries — yet a handful of companies dominate the shipments. HETERO LABS LIMITED holds the largest share at 12.3% (export value: $1.2M). Close behind, GLENMARK PHARMACEUTICALS LIMITED (11.6%, $1.1M). ZYDUS LIFESCIENCES LIMITED (7.0%, $657.3K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.

🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Indomethacin? Top Manufacturers & Their Buyers
Flow of Indomethacin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Indomethacin Supplier Network — Key Market Intelligence
The Indomethacin export market from India is led by HETERO LABS LIMITED, which alone commands a 12.3% share, shipping $1.2M worth of product across 144 shipments. The second-largest exporter, GLENMARK PHARMACEUTICALS LIMITED, contributes $1.1M (11.6%) to the overall market. Combined, the top two suppliers alone account for 23.9% of all Indomethacin exports, indicating a relatively concentrated supply base.
Across all 139 tracked manufacturers, the total Indomethacin export value stands at $9.4M from 1.2K shipments. The market average shipment value is $7.5K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCE SERVICES, receiving $657.3K worth of product.
The combined buyer network spans 7 named purchasing companies, including M/S., CAMBER PHARMACEUTICA, GLENMARK PHARMACEUTICALS INC, EVERSANA LIFE SCIENCE SERVICES, ZEE PHARMACEUTICALS LTD. and 2 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1HETERO LABS LIMITED
HETERO LABS LIMITED is the first-largest Indomethacin exporter from India, with a market share of 12.3% and a total export value of $1.2M across 144 shipments. Their average shipment value of $8.0K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
HETERO LABS LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 61.4% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $708.3K across 88 shipments (61.4% of this supplier's total exports)
• M S TO THE ORDER OF MINT PHARMACEUTICALS — $161.2K across 20 shipments (14.0% of this supplier's total exports)
• M/S. — $140.9K across 18 shipments (12.2% of this supplier's total exports)
• TO THE ORDER — $122.6K across 15 shipments (10.6% of this supplier's total exports)
• CAMBER PHARMACEUTICA — $20.0K across 2 shipments (1.7% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED's per-shipment value of $8.0K is 7% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
2GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the second-largest Indomethacin exporter from India, with a market share of 11.6% and a total export value of $1.1M across 112 shipments. Their average shipment value of $9.7K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• GLENMARK PHARMACEUTICALS INC — $406.4K across 42 shipments (37.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $395.2K across 41 shipments (36.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $119.3K across 12 shipments (11.0% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $105.1K across 11 shipments (9.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $62.6K across 6 shipments (5.7% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED's per-shipment value of $9.7K is 29% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
3ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the third-largest Indomethacin exporter from India, with a market share of 7.0% and a total export value of $657.3K across 13 shipments. Their average shipment value of $50.6K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $657.3K across 13 shipments (100.0% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $50.6K is 573% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
4GLENMARK PHARMACEUTICALS LTD
GLENMARK PHARMACEUTICALS LTD is the fourth-largest Indomethacin exporter from India, with a market share of 6.6% and a total export value of $618.0K across 17 shipments. Their average shipment value of $36.4K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
GLENMARK PHARMACEUTICALS LTD serves 3 named buyers in our database. GLENMARK PHARMACEUTICALS INC is the dominant customer, accounting for 81.5% of this supplier's tracked business. Top customers include:
• GLENMARK PHARMACEUTICALS INC — $504.0K across 14 shipments (81.5% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $81.9K across 2 shipments (13.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $32.1K across 1 shipments (5.2% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LTD's per-shipment value of $36.4K is 384% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
5CADILA HEALTHCARE LIMITED
CADILA HEALTHCARE LIMITED is the fifth-largest Indomethacin exporter from India, with a market share of 3.1% and a total export value of $287.5K across 5 shipments. Their average shipment value of $57.5K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
CADILA HEALTHCARE LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $287.5K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $57.5K is 665% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
6LEBEN LABORATORIES PRIVATE LIMITED
LEBEN LABORATORIES PRIVATE LIMITED is the fifth-largest Indomethacin exporter from India, with a market share of 2.8% and a total export value of $265.1K across 57 shipments. Their average shipment value of $4.7K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
LEBEN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ZEE PHARMACEUTICALS LTD. — $69.8K across 15 shipments (26.3% of this supplier's total exports)
• ZEE PHARMACEUTICALS LTD. — $57.5K across 12 shipments (21.7% of this supplier's total exports)
• KARE PHARMACEUTICALS — $53.6K across 12 shipments (20.2% of this supplier's total exports)
• KARE PHARMACEUTICALS — $50.1K across 11 shipments (18.9% of this supplier's total exports)
• CEYOKA PRIVATE LIMIT — $34.2K across 7 shipments (12.9% of this supplier's total exports)
Key Insight: LEBEN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (57 shipments) at a per-shipment value of $4.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Indomethacin Flows
Once Indomethacin leaves the manufacturing plants of companies like HETERO LABS LIMITED and GLENMARK PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $9.4M. United States absorbs the largest share at 68.0% ($6.4M), followed by Canada (4.3%) and Uganda (3.3%).
In United States — the top destination — named importers include GLENMARK PHARMACEUTICALS INC USA, EVERSANA LIFE SCIENCE SERVICES, GLENMARK PHARMACEUTICALS INC., USA. In Canada, key buyers are MINT PHARMACEUTICALS INC..
This geographic spread reflects Indomethacin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Indomethacin Go? Top Importing Countries & Their Buyers
Trade flow of Indomethacin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Indomethacin imports from India, with a total trade value of $6.4M across 114 shipments — representing a 68.0% share of all Indomethacin exports. The average shipment value of $56.0K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Indomethacin importers in United States: GLENMARK PHARMACEUTICALS INC USA is the largest buyer, accounting for 16.6% ($1.1M) of this market's total imports.
• GLENMARK PHARMACEUTICALS INC USA — $1.1M (16.6% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES — $944.7K (14.8% of United States's total)
• GLENMARK PHARMACEUTICALS INC., USA — $796.0K (12.5% of United States's total)
Key Insight: United States's per-shipment average of $56.0K (645% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Indomethacin imports from India.
2Canada
Canada ranks as the second-largest destination for Indomethacin imports from India, with a total trade value of $405.8K across 10 shipments — representing a 4.3% share of all Indomethacin exports. The average shipment value of $40.6K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Indomethacin importers in Canada: M S TO THE ORDER OF MINT PHARMACEUTICALS is the largest buyer, accounting for 39.7% ($161.2K) of this market's total imports.
• M S TO THE ORDER OF MINT PHARMACEUTICALS — $161.2K (39.7% of Canada's total)
• MINT PHARMACEUTICALS INC. — $132.4K (32.6% of Canada's total)
Key Insight: Canada's per-shipment average of $40.6K (440% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Indomethacin imports from India.
3Uganda
Uganda ranks as the third-largest destination for Indomethacin imports from India, with a total trade value of $305.3K across 8 shipments — representing a 3.3% share of all Indomethacin exports. The average shipment value of $38.2K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Indomethacin importers in Uganda: ZEE PHARMACEUTICALS LTD. is the largest buyer, accounting for 22.9% ($69.8K) of this market's total imports.
• ZEE PHARMACEUTICALS LTD. — $69.8K (22.9% of Uganda's total)
Key Insight: Uganda's per-shipment average of $38.2K (408% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uganda is a key market for Indomethacin imports from India.
4Chile
Chile ranks as the fourth-largest destination for Indomethacin imports from India, with a total trade value of $268.6K across 2 shipments — representing a 2.9% share of all Indomethacin exports. The average shipment value of $134.3K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Indomethacin importers in Chile: SEVEN PHARMA CHILE SPA is the largest buyer, accounting for 45.7% ($122.6K) of this market's total imports.
• SEVEN PHARMA CHILE SPA — $122.6K (45.7% of Chile's total)
Key Insight: Chile's per-shipment average of $134.3K (1688% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chile is a key market for Indomethacin imports from India.
5Tajikistan
Tajikistan ranks as the fifth-largest destination for Indomethacin imports from India, with a total trade value of $226.3K across 0 shipments — representing a 2.4% share of all Indomethacin exports. The average shipment value of $226.3K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations.
Key Insight: Tajikistan's per-shipment average of $226.3K (2912% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tajikistan is a key market for Indomethacin imports from India.
People Also Ask — Indomethacin Supplier & Trade Network
Who are the top suppliers of Indomethacin from India?+
Which companies buy Indomethacin from Indian manufacturers?+
Where does Indomethacin exported from India go?+
What is the market share of the top Indomethacin supplier from India?+
What is the average shipment value for Indomethacin exports from India?+
Is Indomethacin manufactured in India and exported globally?+
Which country imports the most Indomethacin from India?+
Who are the buyers of Indomethacin in Canada?+
How concentrated is the Indomethacin supplier market in India?+
How do I find verified buyers for Indomethacin in specific countries?+
Indomethacin Trade Network — Key Takeaways
- 1HETERO LABS LIMITED is India's dominant Indomethacin exporter with a 12.3% market share and $1.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 139 suppliers collectively account for 43.4% of all tracked Indomethacin exports, with a combined trade value of $9.4M.
- 3United States is the largest destination market, absorbing 68.0% of India's Indomethacin exports ($6.4M). Canada (4.3%) and Uganda (3.3%) follow.
- 4With 1.2K total shipments averaging $7.5K each, the Indomethacin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include M/S., CAMBER PHARMACEUTICA, GLENMARK PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 70 countries
Network value: $9.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Indomethacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Indomethacin.
- 2.Flow Mapping: 139 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,248 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 70 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,248 Verified Shipments
139 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists